Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Esra Saribacak Can"'
Publikováno v:
Turkish Journal of Hematology, Vol 33, Iss 1, Pp 74-75 (2016)
Externí odkaz:
https://doaj.org/article/330d743f22c849b4a4ec9ad8b697af5c
Autor:
Murat Albayrak, Harika Celebi, Aynur Albayrak, Esra Saribacak Can, Vedat Aslan, Birgul Onec, Ipek Coban
Publikováno v:
Eurasian Journal of Medicine, Vol 43, Iss 03, Pp 192-195 (2011)
Imatinib mesylate (STI 571) is one of the fundamental chemotherapeutic agents used in the treatment of the chronic, accelerated and blastic phases of chronic myelocytic leukemia (CML), gastrointestinal stromal tumors and Philadelphia chromosome–pos
Externí odkaz:
https://doaj.org/article/2a140654e05c4a1faf13464c78176390
Autor:
Ozge Soyer Kosemehmetoglu, Aynur Albayrak, Harika Okutan, Esra Saribacak Can, Vedat Aslan, Murat Albayrak, Birgül Öneç, Başak Ünver Koluman
Publikováno v:
Journal of Cancer Research and Therapeutics, Vol 14, Iss 5, Pp 1105-1111 (2018)
Aims: The prognosis of acute myeloid leukemia (AML) in elderly patients is worse due to age and comorbidities. Lately, monotherapy with hypomethylating agents like azacitidine (Aza) has been used to prolong overall survival (OS) in AML patients. Here
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efdcdd8a06242a40e38d7d36aa9f0261
http://www.cancerjournal.net/article.asp?issn=0973-1482
http://www.cancerjournal.net/article.asp?issn=0973-1482
Autor:
Başak Ünver Koluman, Vedat Aslan, Ozge Soyer Kosemehmetoglu, Harika Okutan, Birgül Öneç, Murat Albayrak, Esra Saribacak Can
Publikováno v:
Indian Journal of Hematology and Blood Transfusion. 32:424-430
albayrak, murat/0000-0003-4025-741X WOS: 000386685400009 PubMed: 27812251 Multiple myeloma (MM) is a disease of the geriatric population with a median age at diagnosis of 69 years but most clinicians consider performance status and comorbidities rath
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6699a9b6b35a7443c9d6cb52a4820e33
https://doi.org/10.1007/s12288-015-0618-y
https://doi.org/10.1007/s12288-015-0618-y
Autor:
Gönül Çiçek Şentürk, İrfan Şencan, Murat Albayrak, Esra Saribacak Can, Harika Çelebi, Fatma Aybala Altay
Publikováno v:
Çağdaş Tıp Dergisi, Vol 6, Iss 2, Pp 147-149 (2016)
Volume: 6, Issue: 2 147-149
Çağdaş Tıp Dergisi
Volume: 6, Issue: 2 147-149
Çağdaş Tıp Dergisi
Trombositopeninin nadir bir sebebi: Leptospirozis
A rare cause of thrombocytopenia: Leptospirosis
A rare cause of thrombocytopenia: Leptospirosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51f0178e5512db1d6463712802d4d1c1
http://dergipark.gov.tr/gopctd/issue/24101/255814?publisher=selcuk
http://dergipark.gov.tr/gopctd/issue/24101/255814?publisher=selcuk
Autor:
Aynur Albayrak, Esra Saribacak Can, Murat Albayrak, Vedat Aslan, Harika Çelebi, Birgül Öneç, Ipek Coban
Publikováno v:
Eurasian Journal of Medicine, Vol 43, Iss 03, Pp 192-195 (2011)
Imatinib mesylate (STI 571) is one of the fundamental chemotherapeutic agents used in the treatment of the chronic, accelerated and blastic phases of chronic myelocytic leukemia (CML), gastrointestinal stromal tumors and Philadelphia chromosome-posit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c6b15dee4ef89c06abf5f00f562e22e
http://www.eajm.org/text.php3?id=416
http://www.eajm.org/text.php3?id=416
Publikováno v:
Turkish Journal of Hematology
Turkish Journal of Hematology, Vol 33, Iss 1, Pp 74-75 (2016)
Turkish Journal of Hematology, Vol 33, Iss 1, Pp 74-75 (2016)
Nasal type extranodal natural killer (NK) NK-cell/T-cell lymphoma (NKTCL) is a rare extranodal lymphoma of NK-cell or T-cell origin that most commonly affects immunocompetent middle-aged men of Asian or Native American descent [1]. The pathogenesis i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::781c769c345217a60ff9d2ca3b6f399b
https://doi.org/10.4274/tjh.2015.0169
https://doi.org/10.4274/tjh.2015.0169
Autor:
Ozge Soyer Kosemehmetoglu, Başak Ünver Koluman, Vedat Aslan, Aynur Albayrak, Murat Albayrak, Birgül Öneç, Durdu Mehmet Kos, Harika Okutan, Esra Saribacak Can
Publikováno v:
Journal of Clinical Laboratory Analysis. 31:e22032
albayrak, murat/0000-0003-4025-741X; Onec, Birgul/0000-0003-2824-1044 WOS: 000397489300008 PubMed: 27500465 BackgroundRecent studies have shown a positive correlation between tumor-related immune response markers and the poor outcome in solid tumors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73f9255e142b4d83842d8f040bbadfca
https://doi.org/10.1002/jcla.22032
https://doi.org/10.1002/jcla.22032